Form 4: Elanco CEO Acquires Deferred Stock Units

Elanco Animal Health Inc.'s President and CEO, Jeffrey N. Simmons, acquired 166.1212 deferred stock units at a price of $16.67 per unit.

Summary

• Jeffrey N. Simmons, President, CEO, and Director of Elanco Animal Health Inc., acquired deferred stock units.
• The transaction involved 166.1212 deferred stock units.
• The acquisition price per unit was $16.67.
• Following this transaction, Simmons directly holds 17,387.0337 deferred stock units.
• Each deferred stock unit represents the right to receive one share of common stock or its cash equivalent.
• These units will settle in cash or shares upon termination of employment or in a specified future year, as per the Executive Deferral and Stock Match Plan.

Sentiment

Score: 7

Explanation: The acquisition of additional deferred stock units by the President and CEO, Jeffrey N. Simmons, indicates continued confidence in the company's future performance and aligns his interests with long-term shareholder value.

Positives

• Acquisition of deferred stock units by the CEO indicates continued alignment of management interests with shareholder value.

Negatives

• No direct negatives identified, as the filing reports an acquisition of deferred stock units by an insider.

Risks

• NA (This Form 4 filing primarily details an insider transaction and does not typically include company-specific risk factors.)

Future Outlook

Deferred stock units are set to settle in cash or shares of common stock upon termination of employment or during a specified future year, according to the Executive Deferral and Stock Match Plan.

Management Comments

• NA (This Form 4 is a transactional report and does not typically include direct management commentary or quotes.)

Industry Context

This filing is specific to an insider transaction at Elanco Animal Health Inc. and does not provide broader industry context or trends.

Comparison to Industry Standards

• NA (This filing reports an insider transaction and does not contain information for comparison to industry standards or benchmarks.)

Management Changes

Corporate Governance

Legal Proceedings

• NA (This filing reports an insider transaction and does not mention legal proceedings.)

Related Party Transactions

• Acquisition of deferred stock units by the CEO under the company's Executive Deferral and Stock Match Plan.

Stakeholder Impact

• Shareholders: Potential positive signal due to the CEO's increased stake, aligning management interests with shareholder value.

Next Steps

• Settlement of deferred stock units in cash or common stock upon termination of employment or in a specified future year.

Key Dates

Recommendation

The acquisition of deferred stock units by the CEO, Jeffrey N. Simmons, demonstrates continued alignment of management's interests with long-term shareholder value. While this insider acquisition is a positive signal, the relatively small number of units acquired in this specific transaction does not fundamentally alter the investment thesis, suggesting a 'hold' position for existing investors pending further comprehensive analysis of the company's financial performance and strategic outlook.

Keywords

Elanco, ELAN, Jeffrey N. Simmons, Insider Transaction, Form 4, Deferred Stock Units, Executive Compensation, Animal Health